Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2002 Jan;2(1):59-65.

Immune evasion in human papillomavirus-associated cervical cancer.

Author information

  • 1Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Herston, Australia. r.tindle@mailbox.uq.edu.au

Abstract

Tumour-associated viruses produce antigens that, on the face of it, are ideal targets for immunotherapy. Unfortunately, these viruses are experts at avoiding or subverting the host immune response. Cervical-cancer-associated human papillomavirus (HPV) has a battery of immune-evasion mechanisms at its disposal that could confound attempts at HPV-directed immunotherapy. Other virally associated human cancers might prove similarly refractive to immuno-intervention unless we learn how to circumvent their strategies for immune evasion.

PMID:
11902586
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk